These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
195 related articles for article (PubMed ID: 35507773)
21. Long-term clinical outcomes following treatment with alpha 1-proteinase inhibitor for COPD associated with alpha-1 antitrypsin deficiency: a look at the evidence. Rahaghi FF; Miravitlles M Respir Res; 2017 May; 18(1):105. PubMed ID: 28558837 [TBL] [Abstract][Full Text] [Related]
22. Recurrence of emphysema post-lung transplantation in a patient with alpha 1 antitrypsin deficiency (AATD). Ataya A Respir Med Case Rep; 2020; 31():101309. PubMed ID: 33304809 [TBL] [Abstract][Full Text] [Related]
23. Comparison of exercise training responses in COPD patients with and without Alpha-1 antitrypsin deficiency. Jarosch I; Hitzl W; Koczulla AR; Wencker M; Welte T; Gloeckl R; Janciauskiene S; Kenn K Respir Med; 2017 Sep; 130():98-101. PubMed ID: 29206641 [TBL] [Abstract][Full Text] [Related]
24. The circulating proteinase inhibitor α-1 antitrypsin regulates neutrophil degranulation and autoimmunity. Bergin DA; Reeves EP; Hurley K; Wolfe R; Jameel R; Fitzgerald S; McElvaney NG Sci Transl Med; 2014 Jan; 6(217):217ra1. PubMed ID: 24382893 [TBL] [Abstract][Full Text] [Related]
25. Hawkins P; McEnery T; Gabillard-Lefort C; Bergin DA; Alfawaz B; Shutchaidat V; Meleady P; Henry M; Coleman O; Murphy M; McElvaney NG; Reeves EP ERJ Open Res; 2021 Oct; 7(4):. PubMed ID: 34881324 [TBL] [Abstract][Full Text] [Related]
26. Bronchoscopic Lung Volume Reduction in Patients with Emphysema due to Alpha-1 Antitrypsin Deficiency. Everaerts S; Hartman JE; Van Dijk M; Koster TD; Slebos DJ; Klooster K Respiration; 2023; 102(2):134-142. PubMed ID: 36549279 [TBL] [Abstract][Full Text] [Related]
27. Acute-phase protein α1-antitrypsin inhibits neutrophil calpain I and induces random migration. Al-Omari M; Korenbaum E; Ballmaier M; Lehmann U; Jonigk D; Manstein DJ; Welte T; Mahadeva R; Janciauskiene S Mol Med; 2011; 17(9-10):865-74. PubMed ID: 21494752 [TBL] [Abstract][Full Text] [Related]
28. Alpha-1 Antitrypsin-Deficient Macrophages Have Increased Matriptase-Mediated Proteolytic Activity. Krotova K; Marek GW; Wang RL; Aslanidi G; Hoffman BE; Khodayari N; Rouhani FN; Brantly ML Am J Respir Cell Mol Biol; 2017 Aug; 57(2):238-247. PubMed ID: 28362108 [TBL] [Abstract][Full Text] [Related]
29. Alpha-1 antitrypsin augmentation therapy and biomarkers of elastin degradation. Ma S; Lin YY; He J; Rouhani FN; Brantly M; Turino GM COPD; 2013 Aug; 10(4):473-81. PubMed ID: 23560990 [TBL] [Abstract][Full Text] [Related]
30. Exploring the optimum approach to the use of CT densitometry in a randomised placebo-controlled study of augmentation therapy in alpha 1-antitrypsin deficiency. Parr DG; Dirksen A; Piitulainen E; Deng C; Wencker M; Stockley RA Respir Res; 2009 Aug; 10(1):75. PubMed ID: 19678952 [TBL] [Abstract][Full Text] [Related]
31. A review of augmentation therapy for alpha-1 antitrypsin deficiency. Mohanka M; Khemasuwan D; Stoller JK Expert Opin Biol Ther; 2012 Jun; 12(6):685-700. PubMed ID: 22500781 [TBL] [Abstract][Full Text] [Related]
32. The Biological Effects of Double-Dose Alpha-1 Antitrypsin Augmentation Therapy. A Pilot Clinical Trial. Campos MA; Geraghty P; Holt G; Mendes E; Newby PR; Ma S; Luna-Diaz LV; Turino GM; Stockley RA Am J Respir Crit Care Med; 2019 Aug; 200(3):318-326. PubMed ID: 30965011 [No Abstract] [Full Text] [Related]
33. C3d Elicits Neutrophil Degranulation and Decreases Endothelial Cell Migration, with Implications for Patients with Alpha-1 Antitrypsin Deficiency. Fee LT; Gogoi D; O'Brien ME; McHugh E; Casey M; Gough C; Murphy M; Hopkins AM; Carroll TP; McElvaney NG; Reeves EP Biomedicines; 2021 Dec; 9(12):. PubMed ID: 34944741 [TBL] [Abstract][Full Text] [Related]
34. Methods of Purification and Application Procedures of Alpha1 Antitrypsin: A Long-Lasting History. Viglio S; Iadarola P; D'Amato M; Stolk J Molecules; 2020 Sep; 25(17):. PubMed ID: 32887469 [TBL] [Abstract][Full Text] [Related]
35. Quantum proteolysis by neutrophils: implications for pulmonary emphysema in alpha 1-antitrypsin deficiency. Campbell EJ; Campbell MA; Boukedes SS; Owen CA J Clin Invest; 1999 Aug; 104(3):337-44. PubMed ID: 10430615 [TBL] [Abstract][Full Text] [Related]
39. α Bazzan E; Tinè M; Biondini D; Benetti R; Baraldo S; Turato G; Fagiuoli S; Sonzogni A; Rigobello C; Rea F; Calabrese F; Foschino-Barbaro MP; Miranda E; Lomas DA; Saetta M; Cosio MG Chest; 2018 Sep; 154(3):607-616. PubMed ID: 29763589 [TBL] [Abstract][Full Text] [Related]
40. Alpha 1 Antitrypsin Therapy in Patients with Alpha 1 Antitrypsin Deficiency: Perspectives from a Registry Study and Practical Considerations for Self-Administration During the COVID-19 Pandemic. Herth FJF; Sandhaus RA; Turner AM; Sucena M; Welte T; Greulich T Int J Chron Obstruct Pulmon Dis; 2021; 16():2983-2996. PubMed ID: 34754184 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]